Application 090872
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUMATRIPTAN AND NAPROXEN SODIUM | NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE | TABLET;ORAL | 500MG;EQ 85MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-8755 | Sumatriptan and Naproxen Sodium | sumatriptan and naproxen sodium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-8755 | Sumatriptan and Naproxen Sodium | sumatriptan and naproxen sodium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-8755 | Sumatriptan and Naproxen Sodium | sumatriptan and naproxen sodium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-8755 | Sumatriptan and Naproxen Sodium | sumatriptan and naproxen sodium | Mylan Pharmaceuticals Inc. | ANDA | Current |